• Skip to main content
  • Skip to primary sidebar

Kerry to acquire biotechnology innovation companies

Asia Food Journal
  • Home
  • Latest News
  • Channels
    • Packaging
    • Processing
    • Ingredients
    • Industry
    • Automation
    • Guest Posts
    • Market Trends
  • Subscribe
  • Advertise
  • Event Calendar
  • Contact Us
    • Submit Guest Posts
Share
Leaderboard of Asia Food Journal




Kerry to acquire biotechnology innovation companies

February 21, 2022 by Cath Isabedra

David Gabrielyan/Unsplash

Taste and nutrition company Kerry announced that it has reached agreements to acquire two leading biotechnology companies: c-LEcta and Enmex. These acquisitions are set to expand Kerry’s expertise, manufacturing capacities and tech portfolio.

Germany-based c-LEcta produces high-value targeted enzymes and ingredients, with its functional bioactives utilised in the food and beverage space. It focuses on precision fermentation, optimised bio-transformation and bio-processing.

Leaderboard of Asia Food Journal

On the other hand, Enmex will allow Kerry to expand its manufacturing capabilities to Latin America, as the former is based in Mexico. Enmex showcases a strong manufacturing infrastructure and provides bio-process solutions for F&B.

Commenting on the agreement with c-LEcta, Dr Albert McQuaid, Chief Science and Technology Officer of Kerry, said: “The food and pharmaceutical industries are on the cusp of a new wave of innovation where new developments in biotechnology, synthetic biology and precision fermentation are radically transforming these sectors. c-LEcta is a leader in these new technologies, which includes fermentation-based products such as disruptive new enzymes, and the strategically compelling combination with Kerry will accelerate our innovation capabilities in enzyme engineering, fermentation and bio-process development. Our broad market reach across food and pharma markets, combined with our deep enzyme applications expertise and integrated ingredient technology design, will enable and accelerate the growth potential of c-LEcta’s strong portfolio and technology capabilities while also supporting us in the creation of tastier, more sustainable and healthier products.”

Regarding the acquisition of Enmex, Neil Cracknell, CEO of Kerry Applied Health and Nutrition, said: “Enzymes are increasingly playing a vital role as biocatalysts in the food, beverage and pharmaceutical industries, where they deliver many benefits including improved product quality, increased process efficiency, and reduced food waste, through both minimization of waste and valorisation of waste streams. This strategic acquisition of Enmex will complement Kerry’s existing enzyme portfolio and build on our strength in enzymes for modifying cereals and grains. We see enzymes playing a critical role in helping achieve Kerry’s vision to create a world of sustainable nutrition, which is about providing better nutrition, with better processes, which have less impact on our earth’s resources.”

Visited 1 times, 1 visit(s) today

Other Topics: acquisition, acquisition news, bio-process solutions, bio-process soulutions, bio-processing, bio-transformation, biotech, biotechnology, biotechnology innovation companies, c-LEcta, Enmex, functional ingredients, healthy ingredients, Ingredients, ingredients innovation, Kerry, multifunctional ingredients, nutritional ingredients

Related Articles

  • ModulaSENSE

    Courtesy of dsm-firmenich

    dsm-firmenich launches new ModulaSENSE® maskers: unlocking the full potential of Vertis™ CanolaPRO® in ready-to-mix drinks and protein bars
  • Immersive Experience Hub

    Courtesy of IFF

    IFF expands innovation center in Singapore with new immersive experience hub 
  • precision fermentation

    Courtesy of 21st.BIO

    21st.BIO launches precision fermentation program for bovine alpha-lactalbumin
  • Euromed Ecovadis

    Courtesy of Euromed

    Recognition for outstanding sustainability and ethical credentials
  • Genu-in

    Courtesy of Brenntag Nutrition

    Brenntag Nutrition signs distribution agreement with Genu-in for collagen peptides and gelatin solutions in Asia Pacific 
  • Exotica UMami

    Courtesy of Exotica Umami

    Hong Kong’s revolutionary sauce EXOTICA UMAMI [EX M] stuns industry professionals with its instant boost to flavour, texture, and seasoning
Leaderboard of Asia Food Journal

Primary Sidebar

Stay Connected

Your browser does not support the video tag. Learn More

Trending News

  • Inspection technologyTethered caps: KHS optimizes its inspection… Tethered caps have been mandatory for all non-returnable PET bottles…
  • Euromed EcovadisRecognition for outstanding sustainability and… Euromed, a leading producer of botanical ingredients, has once again…
  • mega prime foodsMega Prime Foods turns 50 with growth plans and… Maker of country’s #1 sardines brand, Mega Sardines, sets sights…
  • greatviewGreatview operates aseptic carton packaging facility… Greatview, a leading global supplier of aseptic carton packaging solutions,…
  • Immersive Experience HubIFF expands innovation center in Singapore with new… Immersive Hub to accelerate innovation, deepen customer collaboration, and strengthen…
  • precision fermentationADM and Asahi Group sign exclusive distribution… ADM (NYSE: ADM), a global leader in innovative solutions from…
  • Exotica UMamiHong Kong’s revolutionary sauce EXOTICA UMAMI [EX M]… The culinary world is abuzz with excitement as the innovative…

Subsribe to Our News Letter

Subscribe To
Our Newsletter


By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

© 2025 Harvest Information. All rights reserved. Privacy Policy.

Become an F&B industry insider

Your go-to resource for all the latest trends, innovations, and news about the food and beverage industry!

 

By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

Disclaimer: Translations on this website are automated using Google Translate. While we strive for accuracy, please be cautious, as machine translations may contain errors. For critical or sensitive content, consider seeking professional human translation. We are not liable for any reliance on the translated content.